CSL (ASX:CSL) share price in focus on currency profit hit, FY24 guidance
Jaz Harrison
June 14, 2023
The CSL Limited (ASX:CSL) share price is in focus as
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The CSL Limited (ASX:CSL) share price is in focus as
Tim Lincoln is the co-founder of Lincoln Indicators. Tim Lincoln
The Resmed CDI (ASX:RMD) share price bounced 6.5% higher today
The CSL Limited (ASX: CSL) share price is up 15%
Nathan Bell, Head of Research at Intelligent Investor, joins Owen
The CSL Limited (ASX:CSL) share price is under the spotlight
The Australian share market or S&P/ASX 200 (INDEXASX: XJO) is
The Australian share market or S&P/ASX 200 (INDEXASX: XJO) opened
The S&P/ASX 200 (INDEXASX: XJO) is expected to open lower
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
